NASDAQ:DNUT • US50101L1061
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for KRISPY KREME INC (DNUT).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-27 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-08-27 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2025-07-18 | B of A Securities | Maintains | Buy -> Buy |
| 2025-07-14 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-05-14 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-05-09 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-04-24 | Truist Securities | Maintains | Buy -> Buy |
| 2025-02-26 | Truist Securities | Reiterate | Buy -> Buy |
| 2025-02-26 | Morgan Stanley | Downgrade | Equal-Weight -> Underweight |
| 2025-02-26 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-01-21 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-11-12 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-10-22 | B of A Securities | Maintains | Buy -> Buy |
| 2024-08-27 | Evercore ISI Group | Reiterate | In-Line |
| 2024-07-23 | HSBC | Upgrade | Hold -> Buy |
| 2024-07-17 | B of A Securities | Maintains | Buy -> Buy |
| 2024-06-10 | Truist Securities | Upgrade | Hold -> Buy |
| 2024-04-08 | B of A Securities | Maintains | Buy -> Buy |
| 2024-04-05 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2024-03-27 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-03-19 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-01-22 | Capital One | Initiate | Equal-Weight |
| 2023-11-20 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2023-10-30 | Truist Securities | Downgrade | Buy -> Hold |
| 2023-10-04 | Truist Securities | Reiterate | Buy -> Buy |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.53B 10.51% | 1.686B 10.21% | 1.665B -1.23% | 1.552B -6.81% | 1.519B -2.13% | 1.619B 6.58% | 1.776B 9.70% | 2.042B 14.98% | 2.186B 7.05% | |
| EBITDA YoY % growth | 143.5M -1.44% | 148.004M 3.14% | 125.596M -15.14% | 132.64M 5.61% | 134.86M 1.67% | 132.73M -1.58% | 149.31M 12.49% | 213.18M 42.78% | 238.68M 11.96% | |
| EBIT YoY % growth | 33.2M -24.55% | 22.11M -33.40% | -8.001M -136.19% | 51.097M 738.63% | 21.67M -57.59% | 32.617M 50.52% | 28.56M -12.44% | 43.86M 53.57% | 62.22M 41.86% | |
| Operating Margin | 2.17% | 1.31% | -0.48% | 3.29% | 1.43% | 2.01% | 1.61% | 2.15% | 2.85% | |
| EPS YoY % growth | 0.30 -26.86% | 0.28 -6.67% | 0.12 -57.14% | -0.20 -183.33% | -0.07 31.83% | -0.01 84.44% | -0.19 -1,664.42% | 0.00 100.00% | -0.02 |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.03 33.09% | -0.03 82.18% | -0.03 -423.03% | 0.01 -88.67% |
| Revenue Q2Q % growth | 364.46M -2.86% | 364.22M -4.09% | 380.72M 1.44% | 406.47M 3.59% |
| EBITDA Q2Q % growth | 28.748M 109.79% | 25.214M -39.80% | 31.301M -68.93% | 41.82M -10.92% |
| EBIT Q2Q % growth | -6.303M 68.80% | -13.097M 52.89% | 1.005M 142.32% | 16.218M 36.73% |
All data in USD
13 analysts have analysed DNUT and the average price target is 4.43 USD. This implies a price increase of 37.91% is expected in the next year compared to the current price of 3.21.
KRISPY KREME INC (DNUT) will report earnings on 2026-05-06.
The consensus EPS estimate for the next earnings of KRISPY KREME INC (DNUT) is -0.03 USD and the consensus revenue estimate is 364.46M USD.
The number of analysts covering KRISPY KREME INC (DNUT) is 13.